Cepeginterferon alfa-2b

Modify Date: 2024-04-06 15:22:35

Cepeginterferon alfa-2b structure	Common Name	Cepeginterferon alfa-2b
	CAS Number	1192706-52-7	Molecular Weight	N/A
	Density	N/A	Boiling Point	N/A
	Molecular Formula	N/A	Melting Point	N/A
	MSDS	N/A	Flash Point	N/A

Use of Cepeginterferon alfa-2b

Cepeginterferon alfa-2b is a pegylated interferon. And Cepeginterferon alfa-2b has PEG with molecular weight of 20 kDa as a pegylated base. Cepeginterferon alfa-2b can be used for research of various diseases, such as hepatitis C virus (HCV), polycythemia vera (PV) and essential thrombocythemia (ET)[1][2].

Name	Cepeginterferon alfa-2b

Description	Cepeginterferon alfa-2b is a pegylated interferon. And Cepeginterferon alfa-2b has PEG with molecular weight of 20 kDa as a pegylated base. Cepeginterferon alfa-2b can be used for research of various diseases, such as hepatitis C virus (HCV), polycythemia vera (PV) and essential thrombocythemia (ET)[1][2].
Related Catalog	Signaling Pathways >> Anti-infection >> HCV Research Areas >> Infection Signaling Pathways >> Cytoskeleton >> Integrin
References	[1]. Melikyan AL, et al. Cepeginterferon alfa-2b in the treatment of chronic myeloproliferative diseases. Ter Arkh. 2018 Aug 17;90(7):23-29. [2]. Znoyko OO, et al. Vozmozhnosti primeneniia tsepeginterferona al'fa-2b v sostave dvukh- (tsepeginterferon al'fa-2b i ribavirin) i trekhkomponentnoĭ (simeprevir, tsepeginterferon al'fa-2b i ribavirin) skhem protivovirusnoĭ terapii khronicheskogo gepatita S. Obzor klinicheskikh issledovaniĭ i opyta povsednevnoĭ klinicheskoĭ praktiki [Possibilities of using cepeginterferon alpha-2b in double (cepeginterferon alfa-2b and ribavirin) and triple (simeprevir, cepeginterferon alpha-2b, and ribavirin) antiviral therapy regimens for chronic hepatitis C. A review of clinical trials and experience of everyday clinical practice]. Ter Arkh. 2016;88(11):156-162. Russian.

Description

Related Catalog

Signaling Pathways >> Anti-infection >> HCV

Research Areas >> Infection

Signaling Pathways >> Cytoskeleton >> Integrin

References

[1]. Melikyan AL, et al. Cepeginterferon alfa-2b in the treatment of chronic myeloproliferative diseases. Ter Arkh. 2018 Aug 17;90(7):23-29.

[2]. Znoyko OO, et al. Vozmozhnosti primeneniia tsepeginterferona al'fa-2b v sostave dvukh- (tsepeginterferon al'fa-2b i ribavirin) i trekhkomponentnoĭ (simeprevir, tsepeginterferon al'fa-2b i ribavirin) skhem protivovirusnoĭ terapii khronicheskogo gepatita S. Obzor klinicheskikh issledovaniĭ i opyta povsednevnoĭ klinicheskoĭ praktiki [Possibilities of using cepeginterferon alpha-2b in double (cepeginterferon alfa-2b and ribavirin) and triple (simeprevir, cepeginterferon alpha-2b, and ribavirin) antiviral therapy regimens for chronic hepatitis C. A review of clinical trials and experience of everyday clinical practice]. Ter Arkh. 2016;88(11):156-162. Russian.

No Any Chemical & Physical Properties

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.

Cepeginterferon alfa-2b

Use of Cepeginterferon alfa-2b

Names

Cepeginterferon alfa-2b Biological Activity

Chemical & Physical Properties

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.